60
Estuary Biotherapeutics raises $103.65M in Regulation D offering
Company raise · Raising · MENLO PARK, CA · Form D filed 2026-10-16
Estuary Biotherapeutics, a Delaware biotech corporation incorporated in 2022, is raising $103.65M under Regulation D exemption 6(b). The company has sold $40.65M to 25 investors so far and is seeking an additional $63M.
Note: First-time filer on EDGAR; no placement agent listed despite $103.65M offering size.
$50M+ raiseFirst raise on EDGARother
Why now — by persona
- Executive & technical recruiting:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- B2B software & services sales:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Commercial banking / treasury:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- D&O and management-liability insurance:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Outsourced accounting / CFO:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
People on the filing
| Wayne E. Sackett | Executive Officer, Director |
| Jacob Bauer | Director |
| Owen Smith | Director |
| Emily Minkow | Director |
Signed by Wayne E. Sackett, Chief Executive Officer.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.